 |


ValveXchange Inc.
Successful First-in-Man Study |
On Sept. 26 and 27, 2011, ValveXchange successfully conducted its “First In Man” implants, ahead of schedule.
All valves are operating flawlessly and all patients recovering normally.
Read the press release. |

W. Randolph Chitwood, MD
Adrian Ebner, MD
Lars Svensson, MD, PhD |
|
ValveXchange, Inc.
6080 Greenwood Plaza Blvd.
Greenwood Village, CO 80111
303-648-4077
888-822-8998 (toll free)
888-313-3993 (fax)
lblankenship@valvexchange.com
Notice: ValveXchange, Inc. products have not been approved by the U.S. FDA or any other Regulatory Agencies. This website contains forward looking statements which represent management's best judgment, but are speculative and may not occur as projected or not at all. Please click here for details of the ValveXchange Website Disclaimers and Notices which apply to all users of this Website.
|
 |

ValveXchange, Inc. (“ValveXchange®” or “VXi”) is dedicated to improving the lives of patients requiring heart valve replacements. VXi is developing a two-piece bioprosthetic tissue valve system that resolves the long standing compromises between conventional mechanical and tissue-based prosthetic valves. Unlike today’s transcatheter valves, the VXi technology is Without Compromise. The VXi exchangeable valve system is being designed to offer leaflet exchange, as well as the original implant, without open-heart surgery and without the safety and longevity compromises of transcatheter approaches.
|
 |